Medical Devices
Computer Software
Healthcare

Haemonetics

74

$97.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.32 (-4.23%) As of 1:53 PM EDT today
-$4.32 (-4.23%) Today

Why Robinhood?

You can buy or sell Haemonetics and other stocks, options, ETFs, and crypto commission-free!

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Read More Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

CEO
Christopher A. Simon
Employees
3,216
Headquarters
Boston, Massachusetts
Founded
1971
Market Cap
4.95B
Price-Earnings Ratio
64.23
Dividend Yield
—
Average Volume
686.57K
High Today
$104.10
Low Today
$96.97
Open Price
$104.10
Volume
410.28K
52 Week High
$140.36
52 Week Low
$63.41

Collections

Medical Devices
Computer Software
Healthcare
Technology
Health
Medical
Software Service
US

HAE News

ReutersApr 2

BRIEF-Haemonetics Acquires Enicor GmbH To Expand Advanced Viscoelastic Testing Portfolio

April 2 (Reuters) - Haemonetics Corp: * HAEMONETICS ACQUIRES ENICOR GMBH TO EXPAND ADVANCED VISCOELASTIC TESTING PORTFOLIO * HAEMONETICS CORP - HAS ACQUIRED A
10

HAE Earnings

$0.00
$0.31
$0.63
$0.94
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
— per share
Actual
Available May 5, Pre-Market

People Also Bought

Boston Scientific

9,359

$34.68

+5.46%

Boston Scientific

9,359

$34.68

+5.46%

Exact Sciences

5,668

$62.71

+0.71%

Intel

52,259

$60.89

+4.21%

Visa

72,647

$173.26

+2.25%

You May Also Like

CRBN
LITB
SANW
JVA
GHIV
XHE
JMST
ECCX
MYOK
SCPE+
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy HAE

Market Price$97.92
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Haemonetics stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up